Search research articles
Contact Us
Filters
Showing results (71-80 of 548) with videos related to
Page
of 55
Sort By:
Cancer Treatment Reviews
|
June 15, 2025
Clearer Horizons: The latest advances in clear cell ovarian cancer treatment
Felix Blanc-Durand, Natalie Ngoi, Diana Lim, et al.
Bulletin Du Cancer
|
December 27, 2021
Traitement médical de première ligne du cancer épithélial de l'ovaire de haut grade: First-line medical treatment of high-grade epithelial ovarian cancer
Frédéric Selle, Jérôme Alexandre, Karine Prulhière, et al.
Cancers
|
April 13, 2023
Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors
Alexandra Lainé, Andrea M Gonzalez-Lopez, Uzma Hasan, et al.
Current Opinion in Oncology
|
June 11, 2009
Is there a role for discontinuing imatinib in patients with advanced gastrointestinal stromal tumour?
Jean-Yves Blay, Antoine Adenis, Isabelle Ray-Coquard, et al.
Frontiers in Oncology
|
January 26, 2024
HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial
Michel Fabbro, Pierre-Jean Lamy, Célia Touraine, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
March 10, 2015
Myxoid liposarcoma with heterologous components: dedifferentiation or metaplasia? A FISH-documented and CGH-documented case report
Noëlle Weingertner, Agnès Neuville, Frédéric Chibon, et al.
The European Journal of General Practice
|
July 18, 2020
Cancer screening and follow-up in general practice: A French nationwide cross-sectional study
Marion Lamort-Bouché, Marine Chardon, Nadir Kellou, et al.
Bulletin Du Cancer
|
June 20, 2017
Laurence Gladieff, Dominique Stoppa Lyonnet, Alain Lortholary, et al.
Expert Opinion on Investigational Drugs
|
February 21, 2023
Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
Ignace Vergote, Isabelle Ray-Coquard, Domenica Lorusso, et al.
The Oncologist
|
November 30, 2005
ET-743: a novel agent with activity in soft tissue sarcomas
Jérôme Fayette, Isabelle Ray Coquard, Laurent Alberti, et al.
Page
of 55
Search research articles
Search
Showing results (71-80 of 548) with videos related to
Sort By:
Page
of 55
Cancer Treatment Reviews
|
June 15, 2025
Clearer Horizons: The latest advances in clear cell ovarian cancer treatment
Felix Blanc-Durand, Natalie Ngoi, Diana Lim, et al.
Bulletin Du Cancer
|
December 27, 2021
Traitement médical de première ligne du cancer épithélial de l'ovaire de haut grade: First-line medical treatment of high-grade epithelial ovarian cancer
Frédéric Selle, Jérôme Alexandre, Karine Prulhière, et al.
Cancers
|
April 13, 2023
Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors
Alexandra Lainé, Andrea M Gonzalez-Lopez, Uzma Hasan, et al.
Current Opinion in Oncology
|
June 11, 2009
Is there a role for discontinuing imatinib in patients with advanced gastrointestinal stromal tumour?
Jean-Yves Blay, Antoine Adenis, Isabelle Ray-Coquard, et al.
Frontiers in Oncology
|
January 26, 2024
HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial
Michel Fabbro, Pierre-Jean Lamy, Célia Touraine, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
March 10, 2015
Myxoid liposarcoma with heterologous components: dedifferentiation or metaplasia? A FISH-documented and CGH-documented case report
Noëlle Weingertner, Agnès Neuville, Frédéric Chibon, et al.
The European Journal of General Practice
|
July 18, 2020
Cancer screening and follow-up in general practice: A French nationwide cross-sectional study
Marion Lamort-Bouché, Marine Chardon, Nadir Kellou, et al.
Bulletin Du Cancer
|
June 20, 2017
Laurence Gladieff, Dominique Stoppa Lyonnet, Alain Lortholary, et al.
Expert Opinion on Investigational Drugs
|
February 21, 2023
Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
Ignace Vergote, Isabelle Ray-Coquard, Domenica Lorusso, et al.
The Oncologist
|
November 30, 2005
ET-743: a novel agent with activity in soft tissue sarcomas
Jérôme Fayette, Isabelle Ray Coquard, Laurent Alberti, et al.
Page
of 55